174 related articles for article (PubMed ID: 2173167)
1. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease.
España F; Vicente V; Tabernero D; Scharrer I; Griffin JH
Thromb Res; 1990 Aug; 59(3):593-608. PubMed ID: 2173167
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro complexes of activated protein C with two inhibitors in baboons.
España F; Gruber A; Heeb MJ; Hanson SR; Harker LA; Griffin JH
Blood; 1991 Apr; 77(8):1754-60. PubMed ID: 1849759
[TBL] [Abstract][Full Text] [Related]
3. Determination of functional and antigenic protein C inhibitor and its complexes with activated protein C in plasma by ELISA's.
España F; Griffin JH
Thromb Res; 1989 Sep; 55(6):671-82. PubMed ID: 2551066
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of activated protein C-protein C inhibitor complex in patients with hypercoagulable states.
Watanabe R; Wada H; Sakakura M; Mori Y; Nakasaki T; Okugawa Y; Gabazza EC; Hayashi T; Nishioka J; Suzuki K; Shiku H; Nobori T
Am J Hematol; 2000 Sep; 65(1):35-40. PubMed ID: 10936861
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of two functional assays for protein C inhibitor/plasminogen activator inhibitor-3 activity.
España F; Hendl S; Gilabert J; Estellés A; Aznar J
Thromb Res; 1993 Jun; 70(5):375-84. PubMed ID: 8397450
[TBL] [Abstract][Full Text] [Related]
6. Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatment.
Tabernero D; España F; Vicente V; Estellés A; Gilabert J; Aznar J
Thromb Haemost; 1990 Jun; 63(3):380-2. PubMed ID: 2169656
[TBL] [Abstract][Full Text] [Related]
7. Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels.
Espana F; Zuazu I; Vicente V; Estellés A; Marco P; Aznar J
Thromb Haemost; 1996 Jan; 75(1):56-61. PubMed ID: 8713780
[TBL] [Abstract][Full Text] [Related]
8. Activation of the protein C pathway in acute sepsis.
Alcaraz A; España F; Sánchez-Cuenca J; Zuazu I; Estellés A; Aznar J; Vicente V
Thromb Res; 1995 Jul; 79(1):83-93. PubMed ID: 7495107
[TBL] [Abstract][Full Text] [Related]
9. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
[TBL] [Abstract][Full Text] [Related]
10. Evidence of activation of the protein C pathway during acute vascular damage induced by Mediterranean spotted fever.
Vicente V; España F; Tabernero D; Estellés A; Aznar J; Hendl S; Griffin JH
Blood; 1991 Jul; 78(2):416-22. PubMed ID: 1648982
[TBL] [Abstract][Full Text] [Related]
11. A qualitative and quantitative analysis of the activation and inactivation of protein C in vivo in a primate model.
Hoogendoorn H; Nesheim ME; Giles AR
Blood; 1990 Jun; 75(11):2164-71. PubMed ID: 2346780
[TBL] [Abstract][Full Text] [Related]
12. Basic residues in the 37-loop of activated protein C modulate inhibition by protein C inhibitor but not by alpha(1)-antitrypsin.
Glasscock LN; Gerlitz B; Cooper ST; Grinnell BW; Church FC
Biochim Biophys Acta; 2003 Jun; 1649(1):106-17. PubMed ID: 12818196
[TBL] [Abstract][Full Text] [Related]
13. Increased activated protein C: protein C inhibitor complex and decreased protein C inhibitor levels in patients with chronic renal failure on maintenance hemodialysis.
Takagi M; Wada H; Mukai K; Minamikawa K; Wakita Y; Deguchi K; Junji N; Hayashi T; Suzuki K; Shiku H
Clin Appl Thromb Hemost; 1999 Apr; 5(2):113-6. PubMed ID: 10725991
[TBL] [Abstract][Full Text] [Related]
14. Factor XIa-alpha 1 antitrypsin complex--elevation in the patients with DIC.
Nishikado H; Komiyama Y; Masuda M; Egawa H; Murata K
Thromb Res; 1986 Nov; 44(4):489-501. PubMed ID: 3492061
[TBL] [Abstract][Full Text] [Related]
15. Physiologic inhibition of human activated protein C by alpha 1-antitrypsin.
Heeb MJ; Griffin JH
J Biol Chem; 1988 Aug; 263(24):11613-6. PubMed ID: 3261294
[TBL] [Abstract][Full Text] [Related]
16. Determination of main inhibitor of activated factor XI.
Nishikado H; Komiyama Y; Masuda M; Egawa H; Murata K
Thromb Res; 1987 Oct; 48(2):145-51. PubMed ID: 3501174
[TBL] [Abstract][Full Text] [Related]
17. Activated protein C: alpha 1-antitrypsin (APC: alpha 1 AT) complex as a marker for in vitro diagnosis of prethrombotic states.
España F; Gilabert J; Vicente V; Estellés A; Vazquez L; Hendl S; Aznar J
Thromb Res; 1992 Jun; 66(5):499-508. PubMed ID: 1523606
[TBL] [Abstract][Full Text] [Related]
18. Turnover of *I-protein C inhibitor and *I-alpha 1-antitrypsin and their complexes with activated protein C.
Laurell M; Stenflo J; Carlson TH
Blood; 1990 Dec; 76(11):2290-5. PubMed ID: 2175221
[TBL] [Abstract][Full Text] [Related]
19. A second plasma inhibitor of activated protein C: alpha 1-antitrypsin.
van der Meer FJ; van Tilburg NH; van Wijngaarden A; van der Linden IK; Briët E; Bertina RM
Thromb Haemost; 1989 Sep; 62(2):756-62. PubMed ID: 2554521
[TBL] [Abstract][Full Text] [Related]
20. Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation.
Heeb MJ; Mosher D; Griffin JH
Blood; 1989 Feb; 73(2):455-61. PubMed ID: 2521800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
